Patents Assigned to Gemin X Pharmaceuticals Canada inc.
  • Patent number: 8420693
    Abstract: The present invention relates to novel Dipyrrole Compounds, compositions comprising a Dipyrrole Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Dipyrrole Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus. The invention also provides screening assays for compounds that can be used in combination with Dipyrrole Compounds for the treatment of cancer or neoplastic disease, inhibition of cancer cell growth, or treatment of viral infections.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: April 16, 2013
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Sasmita Triparthy, Elise Rioux, Gerson Gonzalez
  • Patent number: 8420638
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: April 16, 2013
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrance W. Deyle
  • Patent number: 8173677
    Abstract: The present invention relates to methods for decreasing cellular DNA repair in a patient diagnosed with or suspected to have chronic lymphocytic leukemia (CLL); decreasing cellular NAD+ biosynthesis in a patient diagnosed with or suspected to have CLL; or sensitizing a patient diagnosed with or suspected to have CLL to a DNA damaging therapy. The invention relates to methods for treating a patient diagnosed with or suspected to have CLL.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: May 8, 2012
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Anne Roulston, Pierre Beauparlant
  • Patent number: 7709477
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: May 4, 2010
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle
  • Patent number: 7491745
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: February 17, 2009
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Roy A. Johnson
  • Publication number: 20080318902
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 25, 2008
    Applicant: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle
  • Publication number: 20080318903
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 25, 2008
    Applicant: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Kenza Dairi, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle, Xavuer Billot
  • Patent number: 7425553
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: September 16, 2008
    Assignee: Gemin X Pharmaceuticals Canada inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Terrence W. Doyle